Evidence map›Paper›PMID 31028995›Full record

ArticleInternational journal of surgery case reports2019

Multidisciplinary management of CDH1 germinal mutation and prophylactic management hereditary lobular breast cancer: A case report.

Sara Mirandola, Francesca Pellini, Eleonora Granuzzo, Maya Lorenzi, Beatrice Accordini, Maurizio Ulgelmo, Alessandra Invento, Davide Lombardi, Marina Caldana, Giovanni Paolo Pollini

Open access · goldAbstract read
In one paragraph

Article in International journal of surgery case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Sara MirandolaOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy. Electronic address: sara.mirandola@aovr.veneto.it.
Francesca PelliniOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Eleonora GranuzzoOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Maya LorenziOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Beatrice AccordiniOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Maurizio UlgelmoOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Alessandra InventoOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Davide LombardiOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Marina CaldanaOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Giovanni Paolo PolliniOncologic Surgery Department, Complex Operative Unit of Breast Surgery - Breast Unit AOUI, Verona, Italy.
Breast Center · CHBreast Cancer Care · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGermline CDH1 mutations, classically associated with hereditary diffuse gastric cancer (HDGC), also imply an increased lifetime risk of developing lobular breast cancer (LBC) in a highly penetrant autosomal dominant manner. PRESENTATION OF CASE: We report a 44-year-old woman CDH1 mutation carrier with a strong family history of cancer, who previously had prophylactic total gastrectomy. We registered normal findings at the breast and axilla assessment. Mammography, ultrasonography and breast MRI scans were negative for cancer. In our Institute a bilateral prophylactic mastectomy followed by breast reconstruction was performed. Foci of atypical lobular hyperplasia(ALH) and lobular carcinoma in situ (LCIS) were histologically shown. DISCUSSION: The current consensus guidelines for women with pathogenic CDH1 mutations recommend annual mammography, ultrasound, breast MRI scans and clinical breast examination starting at the age of 35. Due to the well-documented aggressive behavior of this particular type of cancer, bilateral mastectomy and reconstruction would be more beneficial for this kind of high-risk patients.

conclusionConflicting evidences and lacking data about the benefits in terms of overall survival, disease-free survival and the long-term outcomes related to prophylactic bilateral mastectomy for CDH1 mutation carriers restrict the instruction for this type of procedure to selected cases, which should always be managed by a multidisciplinary team.

Indexed as

Case reportCDH1Lobular breast cancerProphylactic bilateral mastectomy

Identifiers

PMID31028995
PMCPMC6484228
OpenAlexW2932498725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.